April 19th 2024, 3:00pm
From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.
April 18th 2024, 7:00pm
Topline data has been released from a trial of antibody-drug conjugate FG-3246 for patients with pretreated, metastatic castration-resistant prostate cancer.
April 18th 2024, 3:00pm
For decades, researchers have been seeking a therapy to improve outcomes for patients with clear cell renal cell carcinoma who underwent a nephrectomy.
April 15th 2024, 7:00pm
Compared to other treatments, patients’ testosterone levels return to baseline levels faster following treatment with Orgovyx.
April 10th 2024, 5:00pm
Anxiety over scans makes sense, but isn’t there more anxiety about other cancer tests, too?
April 9th 2024, 7:00pm
Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D.
April 8th 2024, 10:00pm
When experiencing loss, always look forward and have hope.
April 5th 2024, 7:00pm
Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.
April 4th 2024, 9:00pm
Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.
March 28th 2024, 7:00pm
Across disease stages, Black patients with renal cell carcinoma experience worse survival outcomes than White patients, research has shown.
Realizing How Precious Time is During Non-Hodgkin Lymphoma
Chemo and IMRT Leads to Promising Outcomes in Vulvar Cancer
SBRT and Hormone Therapy May Delay Advanced Prostate Cancer Progression
It’s OK to Dislike Your Body Because of Breast Cancer